Generic Biotech is Coming to the US

This post on the Wall Street Journal blog discusses that soon enough generic biotech drugs will be coming to the US. This is evident with the latest deal with Mylan, a Pennsylvania based generics shop, and Biocan, an Indian biotech company.

Manufacturing generic drugs can be tricky, especially in terms of cracking the market for generic biotechs in a developed country like the US. This is why the partnership with an Indian firm makes sense. Soon enough we should see other companies following this trend.

If you're interested in networking with other professionals in the field of Biosimilars, join our LinkedIn Group here.